Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial.

William JacotPaul CottuFrederique BergerCoraline DubotLaurence Venat-BouvetAlain LortholaryHugues BourgeoisMarc BolletVeronique ServentElisabeth LuporsiMarc EspiéSeverine GuiuVeronique D'HondtVeronique DierasMarie-Paule SablinEtienne BrainSouhir NeffatiJean-Yves PiergaFrancois-Clement Bidard

Published in: Breast cancer research : BCR (2019)

NCT01975142, Registered 03 November 2013.

Keyphrases

circulating tumor cells
metastatic breast cancer
phase iii
study protocol
phase ii
circulating tumor
clinical trial
randomized controlled trial
open label
glycemic control
type diabetes
metabolic syndrome
adipose tissue
skeletal muscle